Business Standard

AstraZeneca Pharma hits 52-week high; stock soars 50% from December low

The stock hit a 52-week high of Rs 1,979, up 6 per cent in the intra-day trade on Wednesday and surpassed its previous high of Rs 1,960 touched on August 27, 2018 on the BSE.

AstraZeneca Pharma hits 52-week high; stock soars 50% from December low
Premium

The share of the top 10 Indian companies in the US generics market nearly doubled from 10.5 per cent in 2012-13 to 19.5 per cent in 2017-18

SI Reporter Mumbai
Shares of AstraZeneca Pharma India hit a 52-week high of Rs 1,979, up 6 per cent, on the BSE in intra-day trade on back of heavy volumes, surpassing its previous high of Rs 1,960 that it touched on August 27, 2018.

The MNC pharmaceutical company's stock has rallied 50 per cent from its recent low of Rs 1,315, touched on December 10, 2018. In comparison, the S&P BSE Sensex gained 2.5 per cent during the same period.

AstraZeneca Pharma had reported a net profit of Rs 29 crore in October-December quarter of financial year 2018-19 against a loss of Rs

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 27 2019 | 1:50 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com